CO5060424A1 - Nuevos 1h-indazoles 1,5 y 3-0 sustituidos con efecto antias- matico, antialergico, antiinflamatorio, inmunomodulador y neuroprotector, procedimientos para su elaboracion y su aplicacion como medicamentos - Google Patents
Nuevos 1h-indazoles 1,5 y 3-0 sustituidos con efecto antias- matico, antialergico, antiinflamatorio, inmunomodulador y neuroprotector, procedimientos para su elaboracion y su aplicacion como medicamentosInfo
- Publication number
- CO5060424A1 CO5060424A1 CO99028289A CO99028289A CO5060424A1 CO 5060424 A1 CO5060424 A1 CO 5060424A1 CO 99028289 A CO99028289 A CO 99028289A CO 99028289 A CO99028289 A CO 99028289A CO 5060424 A1 CO5060424 A1 CO 5060424A1
- Authority
- CO
- Colombia
- Prior art keywords
- indazoles
- choh
- neuroprotector
- immunomodulator
- medications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B37/00—Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged
- B65B37/08—Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged by rotary feeders
- B65B37/12—Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged by rotary feeders of centrifugal type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B37/00—Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged
- B65B37/16—Separating measured quantities from supply
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B37/00—Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged
- B65B37/16—Separating measured quantities from supply
- B65B37/18—Separating measured quantities from supply by weighing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B37/00—Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged
- B65B37/16—Separating measured quantities from supply
- B65B37/20—Separating measured quantities from supply by volume measurement
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B39/00—Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
- B65B39/001—Nozzles, funnels or guides for introducing articles or materials into containers or wrappers with flow cut-off means, e.g. valves
- B65B39/003—Rotating means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B59/00—Arrangements to enable machines to handle articles of different sizes, to produce packages of different sizes, to vary the contents of packages, to handle different types of packaging material, or to give access for cleaning or maintenance purposes
- B65B59/04—Machines constructed with readily-detachable units or assemblies, e.g. to facilitate maintenance
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
- B65B9/10—Enclosing successive articles, or quantities of material, in preformed tubular webs, or in webs formed into tubes around filling nozzles, e.g. extruded tubular webs
- B65B9/20—Enclosing successive articles, or quantities of material, in preformed tubular webs, or in webs formed into tubes around filling nozzles, e.g. extruded tubular webs the webs being formed into tubes in situ around the filling nozzles
- B65B9/213—Enclosing successive articles, or quantities of material, in preformed tubular webs, or in webs formed into tubes around filling nozzles, e.g. extruded tubular webs the webs being formed into tubes in situ around the filling nozzles the web having intermittent motion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Nuevos 1H-indazoles 1, 5 y 3-0- sustituidos caracterizados porquetienen la fórmula general Idonde X, Y, Z, R1 , R2 , y R3 tienen el siguiente significado:X puede ser -SO2 -, -SO-, -(CH2 )p -, -(CH2 )p -O-, -(CH2 )p -(C=O)- -(CH2 )p -(C=O)-NH, -(CH2 )p -CHOH-, -CHOH-(CH2 )p -, -(CH2 )p -CH=CH-, - CH=CH-(CH2 )p -con p = 1...4,Y puede ser -(CH2 )p -, -(CH2 )p -O-, -(CH2 )p -(C=O), -(CH2 )p -(C=O)-NH-, -(CH2 )p -(C=O)-NH-(CH2 )p -, -(CH2 )p -CHOH-, -CHOH-(CH2 )p -, -(CH2 )p -CH=CH, -CH=CH-(CH2 )p - con p = 1...4,Z pude ser -O-, -S-, -SO-, -SO2 -, -O-(CH2 )p - con p = 1...4,-NH-, -NH-(C=O), -NH-(C=O)-NH, -NH-(C=O)-O-, -NH-CH2 -(C=O)- y -NH-(C=O)-CH2 , R1 , R2 y R3 pueden ser iguales o diferentes y pueden tener el siguiente significado:Carbociclos mono, bi o tricíclicos saturados o una o más veces insaturados, con 5...14 eslabones, especialmente fenilo, naftilo, antranilo, fluorenilo; o heterociclos mono, bi o tricíclicos saturados o una o más veces insaturados, con 5...15 eslabones y 1...6 heteroátomos que preferentemente son N, O y S, especialmente tiofenilo, piridinilo, isoxazolilo, benzimidazolilo, benz[1,3]dioxolilo, pirimidinilo, quinililo, quinazolinilo, morfolinilo, pirrolidinilo, fenil [1,2,4]oxadiazolilo, feniltiazolilo,donde los carbociclos o, en su caso, los heterociclos ...
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19821002A DE19821002A1 (de) | 1998-05-11 | 1998-05-11 | Neue 1,5- und 3-O-substituierte 1H-Indazole mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5060424A1 true CO5060424A1 (es) | 2001-07-30 |
Family
ID=7867362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99028289A CO5060424A1 (es) | 1998-05-11 | 1999-05-07 | Nuevos 1h-indazoles 1,5 y 3-0 sustituidos con efecto antias- matico, antialergico, antiinflamatorio, inmunomodulador y neuroprotector, procedimientos para su elaboracion y su aplicacion como medicamentos |
Country Status (23)
Country | Link |
---|---|
US (1) | US6166023A (es) |
EP (1) | EP1077947B1 (es) |
JP (1) | JP2002514626A (es) |
KR (1) | KR20010034853A (es) |
CN (1) | CN1305462A (es) |
AR (1) | AR018347A1 (es) |
AT (1) | ATE248821T1 (es) |
AU (1) | AU754401B2 (es) |
BG (1) | BG104908A (es) |
BR (1) | BR9911787A (es) |
CA (1) | CA2271831A1 (es) |
CO (1) | CO5060424A1 (es) |
DE (2) | DE19821002A1 (es) |
HU (1) | HUP0101821A3 (es) |
IL (1) | IL139359A0 (es) |
NO (1) | NO20005699L (es) |
NZ (1) | NZ508647A (es) |
PL (1) | PL344255A1 (es) |
SK (1) | SK17092000A3 (es) |
TR (1) | TR200003303T2 (es) |
TW (1) | TW509681B (es) |
WO (1) | WO1999058503A1 (es) |
ZA (1) | ZA200006153B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1300116C (zh) * | 2001-04-16 | 2007-02-14 | 卫材株式会社 | 1h-吲唑化合物 |
WO2003076408A2 (en) * | 2002-03-08 | 2003-09-18 | Abbott Laboratories | Indazole derivatives that are activators of soluble guanylate cyclase |
US20040048866A1 (en) * | 2002-03-08 | 2004-03-11 | Teodozyj Kolasa | Indazole derivatives that are activators of soluble guanylate cyclase |
US7417063B2 (en) * | 2004-04-13 | 2008-08-26 | Bristol-Myers Squibb Company | Bicyclic heterocycles useful as serine protease inhibitors |
WO2006056873A2 (en) | 2004-11-29 | 2006-06-01 | Warner-Lambert Company Llc | Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
EP1819673A2 (en) * | 2004-11-30 | 2007-08-22 | Plexxikon, Inc. | Indole derivatives for use as ppar active compounds |
US9108948B2 (en) * | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
JP5203360B2 (ja) * | 2006-06-23 | 2013-06-05 | アボット・ラボラトリーズ | ヒスタミンh3受容体調節剤としてのシクロプロピルアミン誘導体 |
PE20090159A1 (es) | 2007-03-08 | 2009-02-21 | Plexxikon Inc | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs |
US9149463B2 (en) * | 2007-09-18 | 2015-10-06 | The Board Of Trustees Of The Leland Standford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
WO2009071483A1 (en) * | 2007-12-07 | 2009-06-11 | Via Pharmaceuticals, Inc. | 1- (indaz0l-5-yl) -ureas as diacylglycerol acyltransferase inhibitors |
CA2742306A1 (en) * | 2008-11-03 | 2010-05-06 | Chemocentryx, Inc. | Compounds for the treatment of osteoporosis and cancers |
US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
US8853390B2 (en) | 2010-09-16 | 2014-10-07 | Abbvie Inc. | Processes for preparing 1,2-substituted cyclopropyl derivatives |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3118905A (en) * | 1962-07-27 | 1964-01-21 | Riker Laboratories Inc | N-(haloalkyl)-endo-perhydro-4, 7-methanoisoindoles |
GB1054833A (es) * | 1963-08-09 | |||
IL28032A (en) * | 1966-08-29 | 1971-08-25 | Acraf | Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof |
US3470298A (en) * | 1969-01-29 | 1969-09-30 | Acraf | Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids |
GB1435943A (en) * | 1973-02-07 | 1976-05-19 | Delmar Chem | Indazole-derived tertiary amines |
US4537966A (en) * | 1983-12-22 | 1985-08-27 | Pennwalt Corporation | 1-(Aminobenzoyl)-1H-indazol-3-ols |
EP0191520B1 (en) * | 1985-02-12 | 1989-06-21 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. | (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them |
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
JPH10503501A (ja) * | 1994-08-03 | 1998-03-31 | アスタ メディカ アクチエンゲゼルシャフト | 抗喘息、抗アレルギー、抗炎症及び免疫修飾作用を有するインドール、インダゾール、ピリドピロール及びピリドピラゾール誘導体 |
DE19610882A1 (de) * | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1998
- 1998-05-11 DE DE19821002A patent/DE19821002A1/de not_active Withdrawn
-
1999
- 1999-04-01 IL IL13935999A patent/IL139359A0/xx unknown
- 1999-04-01 WO PCT/EP1999/002289 patent/WO1999058503A1/de not_active Application Discontinuation
- 1999-04-01 HU HU0101821A patent/HUP0101821A3/hu unknown
- 1999-04-01 EP EP99927741A patent/EP1077947B1/de not_active Expired - Lifetime
- 1999-04-01 TR TR2000/03303T patent/TR200003303T2/xx unknown
- 1999-04-01 AU AU44995/99A patent/AU754401B2/en not_active Ceased
- 1999-04-01 AT AT99927741T patent/ATE248821T1/de not_active IP Right Cessation
- 1999-04-01 PL PL99344255A patent/PL344255A1/xx unknown
- 1999-04-01 SK SK1709-2000A patent/SK17092000A3/sk unknown
- 1999-04-01 NZ NZ508647A patent/NZ508647A/en unknown
- 1999-04-01 JP JP2000548307A patent/JP2002514626A/ja active Pending
- 1999-04-01 BR BR9911787-8A patent/BR9911787A/pt not_active IP Right Cessation
- 1999-04-01 KR KR1020007012619A patent/KR20010034853A/ko not_active Application Discontinuation
- 1999-04-01 CN CN99807229A patent/CN1305462A/zh active Pending
- 1999-04-01 DE DE59906874T patent/DE59906874D1/de not_active Expired - Fee Related
- 1999-04-23 TW TW088106560A patent/TW509681B/zh active
- 1999-05-05 US US09/305,601 patent/US6166023A/en not_active Expired - Fee Related
- 1999-05-07 CO CO99028289A patent/CO5060424A1/es unknown
- 1999-05-11 AR ARP990102211A patent/AR018347A1/es not_active Application Discontinuation
- 1999-05-11 CA CA002271831A patent/CA2271831A1/en not_active Abandoned
-
2000
- 2000-10-31 ZA ZA200006153A patent/ZA200006153B/en unknown
- 2000-11-03 BG BG104908A patent/BG104908A/bg unknown
- 2000-11-10 NO NO20005699A patent/NO20005699L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE59906874D1 (de) | 2003-10-09 |
CA2271831A1 (en) | 1999-11-11 |
JP2002514626A (ja) | 2002-05-21 |
AR018347A1 (es) | 2001-11-14 |
NO20005699L (no) | 2001-01-08 |
AU4499599A (en) | 1999-11-29 |
BR9911787A (pt) | 2001-04-03 |
AU754401B2 (en) | 2002-11-14 |
US6166023A (en) | 2000-12-26 |
HUP0101821A3 (en) | 2002-05-28 |
PL344255A1 (en) | 2001-10-22 |
SK17092000A3 (sk) | 2001-08-06 |
IL139359A0 (en) | 2001-11-25 |
NO20005699D0 (no) | 2000-11-10 |
WO1999058503A1 (de) | 1999-11-18 |
CN1305462A (zh) | 2001-07-25 |
EP1077947A1 (de) | 2001-02-28 |
DE19821002A1 (de) | 1999-11-18 |
HUP0101821A2 (hu) | 2002-03-28 |
TR200003303T2 (tr) | 2001-01-22 |
TW509681B (en) | 2002-11-11 |
ZA200006153B (en) | 2000-12-06 |
KR20010034853A (ko) | 2001-04-25 |
ATE248821T1 (de) | 2003-09-15 |
EP1077947B1 (de) | 2003-09-03 |
BG104908A (bg) | 2001-07-31 |
NZ508647A (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5060424A1 (es) | Nuevos 1h-indazoles 1,5 y 3-0 sustituidos con efecto antias- matico, antialergico, antiinflamatorio, inmunomodulador y neuroprotector, procedimientos para su elaboracion y su aplicacion como medicamentos | |
AR024839A1 (es) | Compuesto bi o triciclico sustituido, su uso en la fabricacion de un medicamento y composicion farmaceutica que lo comprende. | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
CO5180590A1 (es) | Derivados de camptotecina que tienen actividad anti tumores | |
AR028833A1 (es) | Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion | |
CR6565A (es) | Pirimidina-2,4,6-trionas inhibidores de metloproteinas | |
CO5021131A1 (es) | Compuestos de nuevas 1,2-dihidro-indazol-3-ona 1,2,5-trisus- tituidas, procedimiento para prepararlos; uso de dichos com- puestos por sus efectos antiasmaticos, antialergicos, anti- inflamatorios, inmunomoduladores y neuroprotectores y compo- sicione | |
TR200000289T2 (tr) | Kimyasal bileşimler | |
ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
MXPA05013142A (es) | Compuestos de piridinio [1,2-a]pirimidin-4-ona como agentes anticancer. | |
GEP20084539B (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain | |
ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
HK1076812A1 (en) | Cyanoguanidine prodrugs | |
ES2188888T3 (es) | Derivados morfinoides 8ii) con condensados con heterociclos. | |
ECSP034924A (es) | Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno | |
CY1105366T1 (el) | Ανθελμινθικες συνθεσεις | |
AR043071A1 (es) | Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica | |
CO5080764A1 (es) | Metodos para el tratamiento de enfermedades proliferativas | |
AR030537A1 (es) | Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos | |
MX9302034A (es) | Bencidazoles, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
ES2196069T3 (es) | Derivados morfinoides condensados con heterociclos. | |
ES2084740T3 (es) | Derivados de diamino-5-triazinona y composiciones polimericas autoextinguentes que los contienen. | |
TR199900872T1 (xx) | Bir heteroetinilen radikali ile ba�l� bi-aromatik bile�ikler ve bunlar� ihtiva eden farmas�tik ve kozmetik kompozisyonlar. | |
CO5011066A1 (es) | Compuestos de triazina | |
AR033651A1 (es) | Derivados de pirimidina-2,4,6-triona, composiciones farmaceuticas que contienen dichos compuestos y el empleo de los mismos para la manufactura de un medicamento |